blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2652496

EP2652496 - VACCINE ANTIGENS THAT DIRECT IMMUNITY TO CONSERVED EPITOPES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.11.2018
Database last updated on 11.11.2024
FormerThe patent has been granted
Status updated on  15.12.2017
FormerGrant of patent is intended
Status updated on  04.07.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): MK
published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
The University of Utah Research Foundation
615 Arapeen Drive, Suite 310
Salt Lake City, Utah 84108 / US
[2013/43]
Inventor(s)01 / BOCK, Susan, C.
c/o University of Utah
50 North Medical Drive
Salt Lake City Utah 84132 / US
 [2013/43]
Representative(s)Harrison IP Limited
3 Ebor House
Millfield Lane
Nether Poppleton
York YO26 6QY / GB
[N/P]
Former [2018/03]Harrison IP Limited
3 Ebor House
Millfield Lane
Nether Poppleton, York YO26 6QY / GB
Former [2013/43]D'Arcy, Julia
Harrison IP
1st Floor
Box Tree House
Northminster Business Park, Northfield Lane
York, YO26 6QU / GB
Application number, filing date11849352.712.12.2011
[2018/03]
WO2011US64442
Priority number, dateUS20100457028P13.12.2010         Original published format: US 457028 P
US201161626792P03.10.2011         Original published format: US 201161626792 P
[2013/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012082634
Date:21.06.2012
Language:EN
[2012/25]
Type: A1 Application with search report 
No.:EP2652496
Date:23.10.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 21.06.2012 takes the place of the publication of the European patent application.
[2013/43]
Type: B1 Patent specification 
No.:EP2652496
Date:17.01.2018
Language:EN
[2018/03]
Search report(s)International search report - published on:US21.06.2012
(Supplementary) European search report - dispatched on:EP28.04.2014
ClassificationIPC:G01N33/48, A61K39/00
[2013/43]
CPC:
A61K39/12 (EP,US); C07K14/005 (US); A61K39/145 (US);
A61P31/16 (EP); A61P37/04 (EP); A61K2039/555 (EP,US);
A61K2039/55561 (EP,US); A61K2039/55566 (EP,US); A61K2039/55572 (EP,US);
A61K2039/55577 (EP,US); A61K2039/55583 (EP,US); A61K2039/58 (EP,US);
A61K2300/00 (EP,US); A61K35/76 (EP,US); A61K9/0019 (EP,US);
C12N2760/16034 (EP,US); C12N2760/16111 (EP,US); C12N2760/16121 (EP,US);
C12N2760/16122 (US); C12N2760/16134 (EP,US); C12N2760/16151 (EP,US);
C12N2760/16171 (EP,US) (-)
C-Set:
A61K2039/55561, A61K2039/55566, A61K2039/55583, A61K2039/555, A61K2039/55572, A61K35/76, A61K9/0019, A61K2039/55577, A61K2300/00 (US);
C12N2760/16121, C12N2760/16111, C12N2760/16134, C12N2760/16151, C12N2760/16171 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:IMPFSTOFF-ANTIGENE ZUR AUSSTATTUNG KONSERVIERTER EPITOPE MIT IMMUNITÄT[2013/43]
English:VACCINE ANTIGENS THAT DIRECT IMMUNITY TO CONSERVED EPITOPES[2013/43]
French:ANTIGÈNES DE VACCIN QUI CONTRÔLENT L'IMMUNITÉ CONTRE DES ÉPITOPES CONSERVÉS[2013/43]
Entry into regional phase25.06.2013National basic fee paid 
25.06.2013Search fee paid 
25.06.2013Designation fee(s) paid 
25.06.2013Examination fee paid 
Examination procedure25.06.2013Examination requested  [2013/43]
09.01.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
13.03.2015Amendment by applicant (claims and/or description)
08.05.2015Despatch of a communication from the examining division (Time limit: M06)
16.11.2015Reply to a communication from the examining division
21.01.2016Despatch of a communication from the examining division (Time limit: M04)
23.05.2016Reply to a communication from the examining division
03.07.2017Communication of intention to grant the patent
01.11.2017Fee for grant paid
01.11.2017Fee for publishing/printing paid
01.11.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.05.2015
Opposition(s)18.10.2018No opposition filed within time limit [2018/52]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
13.03.2015Request for further processing filed
13.03.2015Full payment received (date of receipt of payment)
Request granted
25.03.2015Decision despatched
Fees paidRenewal fee
31.12.2013Renewal fee patent year 03
05.12.2014Renewal fee patent year 04
07.12.2015Renewal fee patent year 05
08.12.2016Renewal fee patent year 06
08.12.2017Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.12.2011
AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
MK17.01.2018
NL17.01.2018
PL17.01.2018
PT17.01.2018
RO17.01.2018
RS17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
TR17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
[2020/31]
Former [2020/30]HU12.12.2011
AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
NL17.01.2018
PL17.01.2018
PT17.01.2018
RO17.01.2018
RS17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
TR17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2020/27]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
NL17.01.2018
PL17.01.2018
PT17.01.2018
RO17.01.2018
RS17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
TR17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2020/16]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
NL17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
TR17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2019/40]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
NL17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2019/13]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/52]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/51]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SK17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/50]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SK17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/49]AL17.01.2018
AT17.01.2018
CY17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/47]AL17.01.2018
AT17.01.2018
CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RS17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/46]AL17.01.2018
AT17.01.2018
CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RS17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/40]AT17.01.2018
CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RS17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/39]AT17.01.2018
CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
LV17.01.2018
NL17.01.2018
PL17.01.2018
RS17.01.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/37]CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
NL17.01.2018
PL17.01.2018
NO17.04.2018
GR18.04.2018
Former [2018/36]CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
NL17.01.2018
PL17.01.2018
NO17.04.2018
Former [2018/35]CY17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
NL17.01.2018
NO17.04.2018
Former [2018/34]FI17.01.2018
LT17.01.2018
NL17.01.2018
NO17.04.2018
Documents cited:Search[A]  - PERNILLE HASTE ANDERSEN ET AL, "Prediction of residues in discontinuous B-cell epitopes using protein 3D structures", PROTEIN SCIENCE, (20061101), vol. 15, no. 11, doi:10.1110/ps.062405906, ISSN 0961-8368, pages 2558 - 2567, XP055113267 [A] 1-4

DOI:   http://dx.doi.org/10.1110/ps.062405906
 [A]  - JULIA V PONOMARENKO ET AL, "B-CELL EPITOPE PREDICTION", STRUCTURAL INFORMATICS, (20090101), XP055113769 [A] 1-4
 [A]  - EL-MANZALAWY YASSER ET AL, "Recent advances in B-cell epitope prediction methods", IMMUNOME RESEARCH, BIOMED CENTRAL, LONDON, GB, (20101103), vol. 6, no. Suppl 2, doi:10.1186/1745-7580-6-S2-S2, ISSN 1745-7580, page S2, XP021080944 [A] 1-4

DOI:   http://dx.doi.org/10.1186/1745-7580-6-S2-S2
 [X]  - NAGATA S ET AL, "Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 61, no. 11, doi:10.1016/J.ADDR.2009.07.014, ISSN 0169-409X, (20090930), pages 977 - 985, (20090811), XP026666157 [X] 1,2 * abstract, p.980 col.1 par.2 *

DOI:   http://dx.doi.org/10.1016/j.addr.2009.07.014
International search[Y]US2008032921  (ALEXANDER JEFFERY L [US], et al);
 [X]US2009162383  (PADLAN EDUARDO A [US]);
 [Y]US2010061990  (SASISEKHARAN RAM [US], et al)
by applicant   - GERHARD, W ET AL., "Prospects for Universal Influenza Virus Vaccine", EMERGING INFECTIOUS DISEASES, (2006), vol. 12, doi:doi:10.3201/eid1204.051020, page 569, XP002711940

DOI:   http://dx.doi.org/10.3201/eid1204.051020
    - SUBBARAO, K ET AL., "Development of effective vaccines against pandemic influenza", IMMUNITY, (2006), vol. 24, no. 1, pages 5 - 9
    - KAISER, J., "A One-Size-Fits-All Flu Vaccine", SCIENCE, (2006), vol. 312, page 380
    - CORTI, D. ET AL., "Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine", J CLIN INVEST, (2010), vol. 120, no. 5, pages 1663 - 1673
    - SULLIVAN, J.S. ET AL., "Heterosubtypic antiavian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture", J MOL GENET MED, (2009), vol. 3, no. 2, pages 217 - 24
    - SUI, J. ET AL., "Wide prevalence of heterosubtypic broadly neutralizing human antiinfluenza A antibodies", CLIN INFECT DIS, (2011), vol. 52, no. 8, doi:doi:10.1093/cid/cir121, pages 1003 - 1009, XP055044420

DOI:   http://dx.doi.org/10.1093/cid/cir121
    - WRAMMERT, J. ET AL., "Broadly crossreactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection", J EXP MED, vol. 208, no. 1, pages 181 - 193
    - EPSTEIN, S., "Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature", J INFECT DIS., (2006), vol. 193, pages 49 - 53
    - LYNCH, G.W. ET AL., "Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans", IMMUNOL CELL BIOL, (2011), pages 1 - 10
    - WRAMMERT ET AL., J EXP MED, (2011), vol. 208, no. 1, pages 181 - 193
    - OKUNO, Y. ET AL., "A common neutralizing epitope conserved between the hemagglutinins of influenza A virus HI and H2 strains", J VIROL, (1993), vol. 67, pages 2552 - 8, XP001005475
    - OKUNO, Y. ET AL., "Protection against the mouse-adapted A/FM/l/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among HI and H2 strains", J VIROL., (1994), vol. 68, pages 517 - 20, XP001069854
    - SMIRNOV, Y. ET AL., "Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region", ARCH VIROL., (2000), vol. 145, doi:doi:10.1007/s007050070088, pages 1733 - 41, XP002473326

DOI:   http://dx.doi.org/10.1007/s007050070088
    - STEEL ET AL., "Influenza virus vaccine based on the conserved hemagglutinin stalk domain", MBIO, (201004), vol. 1, no. 1, pages 1 - 9
    - HA. WEI ET AL., "Induction of broadly neutralizing HINI influenza antibodies by vaccination", SCIENCE, (20100715), vol. 329, pages 2060 - 2064
    - BOMMAKANTI ET AL., "Design of an HA2based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge", PROC NATL ACAD SCI U S A, (2010), vol. 107, no. 31, doi:doi:10.1073/PNAS.1007465107, pages 13701 - 6, XP002675041

DOI:   http://dx.doi.org/10.1073/PNAS.1007465107
    - WANG ET AL., "Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.", PROC NATL ACAD SCI USA, (2010), vol. 107, no. 44, doi:doi:10.1073/PNAS.1013387107, pages 18979 - 84, XP002675044

DOI:   http://dx.doi.org/10.1073/PNAS.1013387107
    - KHURANA, "Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets", PLOS MED, (2009), vol. 6, no. 4, doi:doi:10.1371/journal.pmed.1000049, page E1000049, XP055015999

DOI:   http://dx.doi.org/10.1371/journal.pmed.1000049
    - WHITTLE ET AL., "Broadly neutralizing human antibody that recognizes the receptorbinding pocket of influenza virus hemagglutinin", PROC NATL ACAD SCI U S A, (2011), vol. 108, no. 34, doi:doi:10.1073/pnas.1111497108, page 1421621, XP002693351

DOI:   http://dx.doi.org/10.1073/pnas.1111497108
    - YOSHIDA ET AL., "Crossprotective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses", PLOS PATHOG, (2009), vol. 5, no. 3, doi:doi:10.1371/journal.ppat.1000350, page E1000350, XP002541080

DOI:   http://dx.doi.org/10.1371/journal.ppat.1000350
    - BIANCHI, E. ET AL., "Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor", J VIROL., (2005), vol. 79, doi:doi:10.1128/JVI.79.12.7380-7388.2005, pages 7380 - 8, XP002445847

DOI:   http://dx.doi.org/10.1128/JVI.79.12.7380-7388.2005
    - HORVATH, A. ET AL., "A hemagglutinin-based multipeptide construct elicits enhanced protective immune response in mice against influenza A virus infection.", IMMUNOL LETT., (1998), vol. 60, doi:doi:10.1016/S0165-2478(97)00137-5, pages 127 - 36, XP000917227

DOI:   http://dx.doi.org/10.1016/S0165-2478(97)00137-5
    - BARLOW DJ ET AL., "Continuous and discontinuous protein antigenic determinants", NATURE, (1986), vol. 322, doi:doi:10.1038/322747a0, pages 747 - 748, XP009069989

DOI:   http://dx.doi.org/10.1038/322747a0
    - STEVENS, J. ET AL., "Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus.", SCIENCE, (2006), vol. 312, doi:doi:10.1126/science.1124513, pages 404 - 10, XP002533276

DOI:   http://dx.doi.org/10.1126/science.1124513
    - EKIERT, D. C.; G. BHABHA ET AL., "Antibody recognition of a highly conserved influenza virus epitope", SCIENCE, (2009), vol. 324, no. 5924, pages 246 - 51, XP009144786
    - STEVENS, J. ET AL., "Structure and receptor specificity of the hemagglutinin from an H5N] influenza virus", SCIENCE, (2006), vol. 312, doi:doi:10.1126/science.1124513, pages 404 - 10, XP002533276

DOI:   http://dx.doi.org/10.1126/science.1124513
    - KAVERIN, N. ET AL., "Structure of antigenic sites on the haemagglutinin molecule ofH5 avian influenza virus and phenotypic variation of escape mutants", J GEN VIROL., (2002), vol. 83, pages 2497 - 505, XP002547472
    - KAVERIN, N.V. ET AL., "Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N] influenza virus by using monoclonal antibodies", J VIROL, (2007), vol. 81, no. 23, doi:doi:10.1128/JVI.01522-07, pages 12911 - 7, XP008140175

DOI:   http://dx.doi.org/10.1128/JVI.01522-07
    - PHILPOTT, M. ET AL., "Hemagglutinin mutations related to attenuation and altered cell tropism of avirulent avian influenza A virus", J VIROL., (1990), vol. 64, pages 2941 - 7
    - WILEY, D.; I. WILSON; J. SKEHEL, "Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation", NATURE, (1981), vol. 289, pages 373 - 8
    - WEIS, W. ET AL., "Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid", NATURE, (1988), vol. 333, doi:doi:doi:10.1038/333426a0, pages 426 - 31, XP008152712

DOI:   http://dx.doi.org/
    - OKUNO, J VIROL., (1993), vol. 67, pages 2552 - 8
    - EKIERT ET AL., SCIENCE, (2009), page 324
    - SUI VIROLOGY, (2009), vol. 387, pages 473 - 481
    - WRAMMERT ET AL., J EXP MED, (2011), vol. 208, no. 1, pages 181 - 93
    - EKIERT ET AL., SCIENCE, (2011), vol. 333, pages 843 - 50
    - CORTI, D. ET AL., SCIENCE, (2011), vol. 333, pages 850 - 6
    - KHURANA, "Antigenic fingerprinting of H5Nl avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets", PLOS MED, (2009), vol. 6, no. 4, doi:doi:10.1371/journal.pmed.1000049, page E1000049, XP055015999

DOI:   http://dx.doi.org/10.1371/journal.pmed.1000049
    - WHITTLE ET AL., "Broadly neutralizing human antibody that recognizes the receptorbinding pocket of influenza virus hemagglutinin", PROC NATL ACAD SCI USA, (2011), vol. 108, no. 34, doi:doi:10.1073/pnas.1111497108, page 1421621, XP002693351

DOI:   http://dx.doi.org/10.1073/pnas.1111497108
    - HASTE ANDERSEN, P.; M. NIELSEN; O. LUND, "Prediction of residues in discontinuous B-cell epitopes using protein 3D structures", PROTEIN SCI, (2006), vol. 15, no. 11, doi:doi:10.1110/ps.062405906, pages 2558 - 67, XP055113267

DOI:   http://dx.doi.org/10.1110/ps.062405906
    - PARKER, J.M.; D. GUO; R.S. HODGES, "New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites", BIOCHEMISTRY, (1986), vol. 25, no. 19, doi:doi:10.1021/bi00367a013, pages 5425 - 32, XP001062495

DOI:   http://dx.doi.org/10.1021/bi00367a013
    - PONOMARENKO, J.V.; P.E. BOURNE, "Antibody- protein interactions: benchmark datasets and prediction tools evaluation", BMC STRUCT BIOL, (2007), vol. 7, page 64, XP021035783
    - JIN L; FENDLY BM; WELLS JA, "High resolution functional analysis of antibody-antigen interactions", J MOL BIOL., (19920805), vol. 226, no. 3, doi:doi:10.1016/0022-2836(92)90636-X, pages 851 - 65, XP024015345

DOI:   http://dx.doi.org/10.1016/0022-2836(92)90636-X
    - TREANOR, J.J. ET AL., "Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults", J INFECT DIS, (2006), vol. 193, no. 9, doi:doi:10.1086/503050, pages 1223 - 8, XP002445849

DOI:   http://dx.doi.org/10.1086/503050
    - STEVENS, J. ET AL., "Structure of the uncleaved human HI hemagglutinin from the extinct 1918 influenza virus", SCIENCE, (2004), vol. 303, pages 1866 - 70
    - WEI, C.J. ET AL., "Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus", J VIROL, (2008), vol. 82, no. 13, doi:doi:10.1128/JVI.00187-08, pages 6200 - 8, XP009138042

DOI:   http://dx.doi.org/10.1128/JVI.00187-08
    - SHIELDS, D.C. ET AL., "Silent'' sites in Drosophila genes are not neutral: evidence of selection among synonymous codons", MOL BIOL EVOL, (1988), vol. 5, no. 6, pages 704 - 16
    - FRANK, S. ET AL., "Stabilization of short collagen-like triple helices by protein engineering", J MOL BIOL., (2001), vol. 308, doi:doi:10.1006/jmbi.2001.4644, pages 1081 - 9, XP004466182

DOI:   http://dx.doi.org/10.1006/jmbi.2001.4644
    - IWAKI, T. ET AL., "Rapid selection of Drosophila S2 cells with the puromycin resistance gene", BIOTECHNIQUES, (2003), vol. 35, no. 3, pages 482 - 486
    - WEI ET AL., J. VIROL., (2008), vol. 82, page 6200
    - WRAMMERT ET AL., J EXP MED, (2011), vol. 208, page 181
    - KAVERIN ET AL., J VIROL, (2007), vol. 81, page 12911
    - STEVENS ET AL., SCIENCE, (2004), vol. 303, pages 1866 - 70
    - KIM YK ET AL., "Production and N-glycan analysis of secreted human erythropoietin glycoprotein in stably transfected Drosophila S2 cells", BIOTECHNOL BIOENG, (20051120), vol. 92, no. 4, pages 452 - 61
    - BUZAS EI ET AL., "Carbohydrate recognition systems in autoimmunity", AUTOIMMUNITY, (200612), vol. 39, no. 8, doi:doi:10.1080/08916930601061470, pages 691 - 704, XP009111440

DOI:   http://dx.doi.org/10.1080/08916930601061470
    - GAZI, U.; L. MARTINEZ - POMARES, "Influence of the mannose receptor in host immune responses", IMMUNOBIOLOGY, (2009), vol. 214, no. 7, doi:doi:10.1016/j.imbio.2008.11.004, pages 554 - 61, XP026170751

DOI:   http://dx.doi.org/10.1016/j.imbio.2008.11.004
    - STEVENS, J.; O. BLIXT ET AL., "Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus", SCIENCE, (2006), vol. 312, no. 5772, doi:doi:10.1126/science.1124513, pages 404 - 10, XP002533276

DOI:   http://dx.doi.org/10.1126/science.1124513
    - KAVERIN, N. V.; I. A. RUDNEVA ET AL., "Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.", J VIROL, (2007), vol. 81, no. 23, doi:doi:10.1128/JVI.01522-07, pages 12911 - 7, XP008140175

DOI:   http://dx.doi.org/10.1128/JVI.01522-07
    - KAVERIN, N. ET AL., "Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants.", J GEN VIROL., (2002), vol. 83, pages 2497 - 505, XP002547472
    - HASTE ANDERSEN, P.; M. NIELSEN ET AL., "Prediction of residues in discontinuous B-cell epitopes using protein 3D structures.", PROTEIN SCI, (2006), vol. 15, no. 11, doi:doi:10.1110/ps.062405906, pages 2558 - 67, XP055113267

DOI:   http://dx.doi.org/10.1110/ps.062405906
    - HASTE ANDERSEN, P. ET AL., "Prediction of residues in discontinuous B-cell epitopes using protein 3D structures", PROTEIN SCI, (2006), vol. 15, no. 11, doi:doi:10.1110/ps.062405906, pages 2558 - 67, XP055113267

DOI:   http://dx.doi.org/10.1110/ps.062405906
    - PONOMARENKO, J.V.; P.E. BOURNE, "Antibody-protein interactions: benchmark datasets and prediction tools evaluation", BMC STRUCT BIOL, (2007), vol. 7, page 64, XP021035783
    - JIN L ET AL., J MOL BIOL., (1992), vol. 226, no. 3, page 851
    - HASTE ANDERSEN, P, PROTEIN SCI, (2006), vol. 15, no. 11, pages 2558 - 67
    - WHITTLE, J.R.; R. ZHANG; S. KHURANA; L.R. KING; J. MANISCHEWITZ; H. GOLDING; P.R. DORMITZER; B.F. HAYNES; E.B. WALTER; M.A. MOODY, "Broadly neutralizing human antibody that recognizes the receptor binding pocket of influenza virus hemagglutinin", PROC NATL ACAD SCI USA, (2011), vol. 108, no. 34, doi:doi:10.1073/pnas.1111497108, pages 14216 - 21, XP002693351

DOI:   http://dx.doi.org/10.1073/pnas.1111497108
    - KONG, W.P. ET AL., "Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination", PROC NATL ACAD SCI USA, (2006), vol. 103, no. 43, doi:doi:10.1073/pnas.0607564103, pages 15987 - 91, XP002445284

DOI:   http://dx.doi.org/10.1073/pnas.0607564103
    - SKEHEL, J.J.; D.C. WILEY, "Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin", ANNU REV BIOCHEM, (2000), vol. 69, pages 531 - 69
    - OKUNO, Y.; Y. ISEGAWA; F. SASAO; S. UEDA, "A common neutralizing epitope conserved between the hemagglutinins of influenza A virus HI and H2 strains", J VIROL, (1993), vol. 67, no. 5, pages 2552 - 8, XP001005475
    - COLER, R.N. ET AL., "A synthetic adjuvant to enhance and expand immune responses to influenza vaccines", PLOS ONE, (2010), vol. 5, no. 10, page E13677
    - KHURANA, S. ET AL., "Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N] influenza virus", SCI TRANSL MED, (2010), vol. 2, no. 15, page 15RA5
    - KHURANA ET AL., PLOS MED, (2009), vol. 6, no. 4, page E1000049
    - WHITTLE ET AL., PROC NATL ACAD SCI USA, (2011), vol. 108, no. 34, page 1421621
    - YOSHIDA ET AL., PLOS PATHOG, (2009), vol. 5, no. 3, page E1000350
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.